Does FULVESTRANT Cause Second primary malignancy? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Second primary malignancy have been filed in association with FULVESTRANT (FULVESTRANT). This represents 0.5% of all adverse event reports for FULVESTRANT.
96
Reports of Second primary malignancy with FULVESTRANT
0.5%
of all FULVESTRANT reports
30
Deaths
37
Hospitalizations
How Dangerous Is Second primary malignancy From FULVESTRANT?
Of the 96 reports, 30 (31.3%) resulted in death, 37 (38.5%) required hospitalization, and 18 (18.8%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FULVESTRANT. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does FULVESTRANT Cause?
Malignant neoplasm progression (3,221)
Fatigue (1,840)
Death (1,677)
Metastases to bone (1,525)
Nausea (1,510)
Neutropenia (1,486)
Metastases to liver (1,241)
Breast cancer metastatic (1,165)
Diarrhoea (1,163)
Dyspnoea (858)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which FULVESTRANT Alternatives Have Lower Second primary malignancy Risk?
FULVESTRANT vs FURAZOLIDONE
FULVESTRANT vs FUROSEMIDE
FULVESTRANT vs FUROSEMIDE\SPIRONOLACTONE
FULVESTRANT vs FUSIDATE
FULVESTRANT vs FUSIDIC ACID